STON2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.972800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.960000E-01
Normal-vs-Stage2
9.120000E-01
Normal-vs-Stage3
9.315400E-01
Normal-vs-Stage4
7.889400E-01
Stage1-vs-Stage2
6.280600E-01
Stage1-vs-Stage3
4.026200E-01
Stage1-vs-Stage4
9.189200E-01
Stage2-vs-Stage3
6.359800E-01
Stage2-vs-Stage4
7.617200E-01
Stage3-vs-Stage4
5.359600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.116000E-01
Normal-vs-AfricanAmerican
9.350800E-01
Normal-vs-Asian
7.424400E-01
Caucasian-vs-AfricanAmerican
7.159000E-01
Caucasian-vs-Asian
8.579600E-01
AfricanAmerican-vs-Asian
6.909400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.510200E-01
Normal-vs-Female
7.929200E-01
Male-vs-Female
4.467400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.669600E-01
Normal-vs-Age(41-60Yrs)
4.736200E-01
Normal-vs-Age(61-80Yrs)
8.719400E-01
Normal-vs-Age(81-100Yrs)
9.837400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.468800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.599400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.235410E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.606430E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.298350E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.794400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.948600E-01
Normal-vs-Daily Drinker
4.488000E-01
Normal-vs-Weekly Drinker
7.365800E-01
Normal-vs-Occasional Drinker
3.535400E-01
Normal-vs-Social Drinker
8.158400E-01
Non Drinker-vs-Daily Drinker
4.001700E-02
Non Drinker-vs-Weekly Drinker
4.289800E-01
Non Drinker-vs-Occasional Drinker
2.558100E-02
Non Drinker-vs-Social Drinker
5.249600E-01
Daily Drinker-vs-Weekly Drinker
3.160300E-02
Daily Drinker-vs-Occasional Drinker
5.202800E-01
Daily Drinker-vs-Social Drinker
3.109600E-01
Weekly Drinker-vs-Occasional Drinker
1.617550E-02
Weekly Drinker-vs-Social Drinker
2.835200E-01
Occasional Drinker-vs-Social Drinker
1.498240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.219200E-01
Normal-vs-Grade 2
9.919000E-01
Normal-vs-Grade 3
9.898400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.165800E-01
Grade 1-vs-Grade 3
4.468400E-01
Grade 1-vs-Grade 4
8.219200E-01
Grade 2-vs-Grade 3
9.739000E-01
Grade 2-vs-Grade 4
9.919000E-01
Grade 3-vs-Grade 4
9.898400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.300200E-01
Normal-vs-NonDiabetic
6.543400E-01
Diabetic-vs-NonDiabetic
2.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.813400E-01
Normal-vs-NoPancreatitis
7.346400E-01
Pancreatitis-vs-NoPancreatitis
7.549800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.435000E-01
Normal-vs-N1
7.739000E-01
N0-vs-N1
3.812000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.488600E-01
Normal-vs-TP53-NonMutant
6.942800E-01
TP53-Mutant-vs-TP53-NonMutant
2.652200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
